ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/21/2025
Back to search
Official data from USPTO
19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/22/2025
Trademark type
Combined
Nice classes
44
Filing date
12/11/2014
Registration date
04/26/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/22/2022
Last transaction
08/22/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2014-11-00
First use in commerce
2014-11-00
Drawing code
3
Owner type
22
Owner location
ST. GALLEN, CH
Examiner
GILLES, DEBORAH
Law office
M10
Current location
TMO LAW OFFICE 110
Mark description
The mark consists of a stylized representation of K from a periodic table of elements with the letter "K" in the middle of an incomplete circle containing a complete circle on one of the ends of the circle lines that is incomplete, all encompassed in a square with the number "19" in the bottom left corner and the number "39.10" in the bottom right corner; to the right are the words "HYPERKALEMIA CLINICAL INSIGHTS".
Holders and representatives
Holders
VIFOR (INTERNATIONAL) AG (VIFOR (INTERNATIONAL) LTD.) (VIFOR (INTERNATIONAL) INC.)
VIFOR PHARMA, INC.
Relypsa, Inc.
Representatives
Julie C. Scheipeter Stinson LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing medical informationnews and commentary to health care professionals in the field of hyperkalemia
Publications
History of USPTO decisions and trademark events.
38 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/26/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/19/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/22/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/22/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/22/2022
E815
TEAS SECTION 8 & 15 RECEIVED
04/25/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/26/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/09/2016
PUBO
PUBLISHED FOR OPPOSITION
02/09/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/20/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/30/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
12/30/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/30/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
12/30/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/30/2015
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/30/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/22/2015
GNRT
NON-FINAL ACTION E-MAILED
10/22/2015
CNRT
NON-FINAL ACTION WRITTEN
10/22/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/18/2015
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/18/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/01/2015
GNRT
NON-FINAL ACTION E-MAILED
04/01/2015
CNRT
NON-FINAL ACTION WRITTEN
04/01/2015
DOCK
ASSIGNED TO EXAMINER
03/24/2015
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/17/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/16/2014
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
12/16/2014
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/16/2014
NWAP
NEW APPLICATION ENTERED
12/15/2014
Continuous trademark protection
Get notified about every new filing that threatens 19 K 39.10 HYPERKALEMIA CLINICAL INSIGHTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.